Molnupiravir Active Metabolite–N4 hydroxycytidine causes Cytotoxicity to Mammalian Cells In Vitro

Pakotiprapha et al., ASPET 2024 Annual Meeting Abstract - Toxicology, doi:10.1124/jpet.212.937140, May 2024
In vitro study showing cytotoxicity of N4-hydroxycytidine (NHC), the active metabolite of molnupiravir, at concentrations relevant to therapeutic doses of molnupiravir in COR-L23 and HepG2 cancer cell lines, and compared with cytotoxicity in normal HaCaT cells. NHC showed cytotoxicity in all three lines, with HaCaT cells showing lower IC50 values compared to both cancer cell lines at 3 and 5 days of treatment. The therapeutic dose of molnupiravir results in serum NHC concentrations close to the IC50 values obtained in this study.
Potential risks of molnupiravir include the creation of dangerous variants, and mutagenicity, carcinogenicity, teratogenicity, and embryotoxicity1-15. Multiple analyses have identified variants potentially created by molnupiravir16-20. Studies show significantly increased risk of acute kidney injury21, cardiovascular toxocity22, and neurological symptoms21. Treatment may increase viral rebound23,24.
Pakotiprapha et al., 13 May 2024, peer-reviewed, 6 authors.
In vitro studies are an important part of preclinical research, however results may be very different in vivo.
DOI record: { "DOI": "10.1124/jpet.212.937140", "URL": "http://dx.doi.org/10.1124/jpet.212.937140", "alternative-id": [ "10.1124/jpet.212.937140" ], "author": [ { "affiliation": [], "family": "Pakotiprapha", "given": "Jessada", "sequence": "first" }, { "affiliation": [], "family": "Tangjittham", "given": "Krittin", "sequence": "additional" }, { "affiliation": [], "family": "Rimdusit", "given": "Tanaboon", "sequence": "additional" }, { "affiliation": [], "family": "Prajuabjinda", "given": "Onmanee", "sequence": "additional" }, { "affiliation": [], "family": "Poomirat", "given": "Saovapak", "sequence": "additional" }, { "affiliation": [], "family": "Sangsiri", "given": "Sutheera", "sequence": "additional" } ], "container-title": "ASPET 2024 Annual Meeting Abstract - Toxicology", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2024, 5, 13 ] ], "date-time": "2024-05-13T22:52:53Z", "timestamp": 1715640773000 }, "deposited": { "date-parts": [ [ 2024, 5, 13 ] ], "date-time": "2024-05-13T22:52:54Z", "timestamp": 1715640774000 }, "event": "ASPET 2024 Annual Meeting Abstract", "indexed": { "date-parts": [ [ 2024, 5, 14 ] ], "date-time": "2024-05-14T00:37:14Z", "timestamp": 1715647034068 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2024, 5, 13 ] ] }, "link": [ { "URL": "https://syndication.highwire.org/content/doi/10.1124/jpet.212.937140", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "36", "original-title": [], "prefix": "10.1124", "published": { "date-parts": [ [ 2024, 5, 13 ] ] }, "published-online": { "date-parts": [ [ 2024, 5, 13 ] ] }, "published-print": { "date-parts": [ [ 2024, 6 ] ] }, "publisher": "American Society for Pharmacology and Experimental Therapeutics", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "http://jpet.aspetjournals.org/lookup/doi/10.1124/jpet.212.937140" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Molnupiravir Active Metabolite–N4 hydroxycytidine causes Cytotoxicity to Mammalian Cells<i>In Vitro</i>", "type": "proceedings-article" }